Oral Drug Delivery Solutions
-
Formulation Strategies For Poorly Soluble Molecules
10/15/2025
As the number of poorly soluble compounds continues to increase in the industry development pipeline, conventional formulation strategies may not be sufficient to achieve acceptable levels of solubility in the gastrointestinal tract and hence absorption into the systemic circulation.
-
Modified-Release Formulation Strategies
10/15/2025
Learn what oral modified-release (MR) dosage forms can offer and why they continue to rise in popularity.
-
Manufacturing For Oral Solid Dose Success
6/30/2025
Adare Pharma Solutions provides end-to-end CDMO services for oral solid dose drugs, enabling efficient development, manufacturing, and packaging with advanced technologies and global scale.
-
Battelle: 90 Years Of Innovation
3/19/2025
Battelle, a leading nonprofit in applied science and technology, drives innovation in national security, healthcare, environment, and education while managing research labs and advancing critical discoveries.
-
Streamlining The Generic Combination Device Design Assessment Process
3/19/2025
A new six-phase assessment process simplifies regulatory approval for generic drug-device combination products, reducing costs and timelines while maintaining safety, effectiveness, and substitutability with reference-listed drugs.
-
Formulation And Manufacturing Equipment
7/25/2024
AustinPx offers integrated GMP manufacturing services for oral dosage forms with a full complement of analytical development and testing capabilities.
-
Battelle uLAB
3/21/2024
This comprehensive suite of services encompasses the entire spectrum of user research, starting from the conceptualization of study designs to meticulous data analysis and comprehensive reporting.
-
Pharmaceutical Development
4/24/2023
Developing an optimized formulation tailored to your API nanoparticles is critical to unlocking their full potential.
-
Controlled Expansion Of Supercritical Solutions (CESS®) Technology
4/24/2023
Nanoform’s award-winning Controlled Expansion of Supercritical Solutions (CESS®) technology is a bottom-up nanoparticle engineering approach that enables the creation of API nanoparticles and can unlock the full therapeutic potential of small molecule drugs.
-
Global Experts In Nanotechnology And Drug Particle Engineering
3/9/2023
Discover the nanoparticle engineering, formulation and GMP manufacturing services that can drive forward your market success and unlock the power of “small."